Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension
NCT01472796Phase 4Unknown
- Sponsor
- Wayne State University
- Start
- Jul 2011
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypertension (HTN) comparing Tekturna + Vitamin D with Tekturna + Placebo (2 arms). Primary endpoint: Change in Ambulatory Systolic Blood Pressure at 18 weeks. Status: unknown.
02
Drugs
vitamin d
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01472796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472796.